202 related articles for article (PubMed ID: 9068523)
21. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Holt P; Najm J; Sowton E
Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
[TBL] [Abstract][Full Text] [Related]
22. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
23. [Angiotensin-converting enzyme, quinapril, in treating chronic cardiac failure].
Gadzhiev AN
Ter Arkh; 2003; 75(1):51-5. PubMed ID: 12652958
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
[TBL] [Abstract][Full Text] [Related]
25. Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure.
Jondeau G; Katz SD; Zohman L; Goldberger M; McCarthy M; Bourdarias JP; LeJemtel TH
Circulation; 1992 Nov; 86(5):1351-6. PubMed ID: 1423946
[TBL] [Abstract][Full Text] [Related]
26. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
27. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity while minimizing the increase in ventricular wall stress.
Demopoulos L; Bijou R; Fergus I; Jones M; Strom J; LeJemtel TH
J Am Coll Cardiol; 1997 Mar; 29(3):597-603. PubMed ID: 9060899
[TBL] [Abstract][Full Text] [Related]
28. Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors.
Esposito F; Mathieu-Costello O; Shabetai R; Wagner PD; Richardson RS
J Am Coll Cardiol; 2010 May; 55(18):1945-54. PubMed ID: 20430267
[TBL] [Abstract][Full Text] [Related]
29. Quinapril therapy in patients with chronic mitral regurgitation.
Schön HR; Schröter G; Barthel P; Schömig A
J Heart Valve Dis; 1994 May; 3(3):303-12. PubMed ID: 8087269
[TBL] [Abstract][Full Text] [Related]
30. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
31. Further increase in oxygen uptake during early active recovery following maximal exercise in chronic heart failure.
Daida H; Allison TG; Johnson BD; Squires RW; Gau GT
Chest; 1996 Jan; 109(1):47-51. PubMed ID: 8549215
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
[TBL] [Abstract][Full Text] [Related]
33. Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacity.
Jondeau G; Katz SD; Toussaint JF; Dubourg O; Monrad ES; Bourdarias JP; LeJemtel TH
J Am Coll Cardiol; 1993 Nov; 22(5):1399-402. PubMed ID: 8227797
[TBL] [Abstract][Full Text] [Related]
34. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
[TBL] [Abstract][Full Text] [Related]
36. Prediction of acceptable physical work loads based on responses to prolonged arm and leg exercise.
Aminoff T; Smolander J; Korhonen O; Louhevaara V
Ergonomics; 1998 Jan; 41(1):109-20. PubMed ID: 9468809
[TBL] [Abstract][Full Text] [Related]
37. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation.
Schön HR; Dorn R; Barthel P; Schömig A
J Heart Valve Dis; 1994 Sep; 3(5):500-9. PubMed ID: 8000584
[TBL] [Abstract][Full Text] [Related]
38. Differential Responses of Post-Exercise Recovery of Leg Blood Flow and Oxygen Uptake Kinetics in HFpEF versus HFrEF.
Thompson RB; Pagano JJ; Mathewson KW; Paterson I; Dyck JR; Kitzman DW; Haykowsky MJ
PLoS One; 2016; 11(10):e0163513. PubMed ID: 27701422
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
[TBL] [Abstract][Full Text] [Related]
40. Quinapril demonstrates improved endothelium-mediated vasodilation in patients with chronic heart failure.
Compr Ther; 1998 Jan; 24(1):38. PubMed ID: 9452901
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
